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ABSTRACT
Re-irradiation is frequently performed in radiotherapy (RT) departments. We present an optimization methodology
that takes the previous irradiation into account. A 68-year-old female patient suffering from rectal adenocarcinoma,
who had previously undergone RT for metastases to the right iliac bone, presented with a recurrence of metastasis
to the L5 and the left sacroiliac joint. Re-irradiation was performed using volumetric modulated arc therapy (VMAT).
We proceeded to a registration of the previous RT planning CT and RT doses to the new planning CT. Virtual
volumes corresponding to the intersection of the small bowel (SB) and each isodose structure were created. We
calculated the maximal dose (Dmax) that each virtual structure could receive and considered them as constraints.
We called this technique modified VMAT. We compared this technique with a standard VMAT plan and a three-
dimensional RT plan. Using the modified VMAT technique, a total dose of 20Gy in five fractions of 4Gy was
delivered to the planning target volume without any acute toxicity. A composite dosimetry was realized with each
technique to compare the dose given to the already irradiated SB. We calculated the Dmax received by the already
irradiated SB in equivalent dose of 2Gy fractions. The Dmax was 46.8, 60 and 52Gy for modified VMAT, standard
VMAT and three-dimensional RT, respectively. Dose deformation was used to create new constraint structures to
optimize the dose delivered to surrounding tissues. This methodology is readily feasible in clinical routine to
optimize the re-irradiation process.
INTRODUCTION
Thanks to new treatment techniques in radiotherapy
(RT) and oncology, patients suffering from cancer live
longer than before.1 Nowadays, we frequently observe
patients who need several courses of RT.2 Sometimes,
re-irradiation is needed in the same area that had pre-
viously been treated. Intersection with the previous
treatment area is a reason to reduce the dose in order
to not exceed a critical dose appropriate for each organ.
The critical issue in the re-irradiation setting, dealing
not only with palliative patients but also those with
curative intent, is to avoid side effects in the surround-
ing normal organs. Therefore, the dose delivered to the
target is often compromised. Intensity-modulated radio-
therapy (IMRT) has been a major advancement in RT,
improving critical organ sparing by using the concept
of inverse planning. More recently, deformable image
registration (DIR), used to warp an image on another,
has been integrated into many steps of the RT process.3
The goal of this study is to present a new methodology
based on DIR that takes into account the previous irra-
diation in order to optimize the re-irradiation plan.
MATERIALS ANDMETHODS
Patient
This new concept will be described on a single patient. A
68-year-old female patient suffering from rectal adenocar-
cinoma with initial multimetastatic evolution (liver, bones
and lung) since September 2013 was referred. She under-
went a first course of RT for hyperalgic bone metastases to
the seventh cervical vertebra, left shoulder, right iliac bone
and right femoral articulation towards the end of 2013. A
total dose of 30Gy in 10 fractions of 3Gy five times a week
was delivered to the right iliac bone and the right femoral
articulation. A three-dimensional conformal RT (3D RT)
technique was used to perform this treatment. Following
RT, she was offered palliative chemotherapy with FOLFIRI
(folinic acid, fluorouracil and irinotecan) and bevacizu-
mab. In April 2014, she presented with recurrence of pain
that was localized to the front of the fifth lumbar vertebra.
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A CT scan confirmed metastatic infiltration of the L5 and the
left sacroiliac joint.
Methodology
Simulation
In order to reproduce the initial set-up, the patient was positioned
supine on a thin foam mattress with a foam support under the
knees, in accordance with the initial planning CT scan. CT scan
was performed with a Toshiba Aquilion LBÒ (Toshiba Medical
Systems, Zoetermeer, Netherlands), with an image thickness of
2mm as in the first planning CT. CT acquisition was made to
cover the whole pevis area and the lumbar spine.
Target and organs at risk definition
The clinical target volume corresponded to the L5 vertebra and
the left sacroiliac joint. The planning target volume (PTV) was
created by a 5mm automatic expansion of the clinical target vol-
ume. The small bowel (SB), which was the most critical organ of
this area and had already been irradiated, was delineated with
respect to the peritoneal cavity.4 Structures and registration were
performed using VelocityAI 3.1.0Ò software (Velocity Medical
Solutions, Atlanta, GA). We first rigidly aligned the previous
treatment planning CT (CT1) on the new planning CT (CT2)
according to the bony structures. Then, a DIR between CT1 and
CT2 was performed to create a transformation that was applied
on the previous dose to fit with CT2. The quality of deformable
registration was visually checked by the physician. Once the previ-
ous dose had been deformed on CT2, an automatic delineation of
isodoses was performed. An isodose was created for every 5Gy
interval. In order to define different constraint volumes, we deter-
mined a virtual volume corresponding to the intersection of SB
and every isodose structure and called it OARsbX (X representing
the corresponding isodose). We obtained six virtual structures.
Each of these structures represented the estimated part of the SB
that had already received a part of the previous irradiation. The
volume corresponding to the intersection between the 5Gy iso-
dose and the SB was defined as the already irradiated SB (AISB).
Treatment planning
The new RT plan consisted of a volumetric modulated arc ther-
apy (VMAT) treatment. An inverse dosimetry plan was per-
formed using the Monaco treatment planning system (TPS)
(Elekta Instrument AB, Stockholm, Sweden). Owing to the pre-
vious treatment being hypofractionated RT, each of the OARsbX
was computed in equivalent dose of 2Gy fractions (EQD2).5,6
We chose an a/b ratio of 2Gy for the SB.7 The Radiation Ther-
apy Oncology Group 08228 study constraints were used to deter-
mine the appropriate maximal dose (Dmax) to deliver to each of
the OARsbX without exceeding the Dmax of 50Gy. OARsbXs
were used as constraint volumes, where Dmax = 50 – OARsb-
XEQD2. We calculated the Dmax that each OARsbX could receive
and entered them into the TPS as constraints. This methodology
was designed to optimize the new treatment integrating the pre-
vious treatment. This technique was named modified VMAT.
Comparison
VMAT is used worldwide and is well known to reduce gastroin-
testinal toxicity.9,10 3D RT could be a simple, fast and efficient
treatment that completely avoids the AISB. For comparison, we
also computed a 3D RT and a VMAT plan without using
OARsbX constraints. For each plan, we measured the Dmax and
the minimum dose (Dmin) within the target volume.
11 We com-
pared the three re-irradiation plans and also performed three
composite dosimetries of the first and second irradiation to
Figure 1. Radiotherapy plan of each technique tested: (a) VMAT*; (b) VMAT; and (c) 3D RT. 3D RT, three-dimensional conformal
radiotherapy; PTV, planning treatment volume; VMAT, volumetric modulated arc therapy; VMAT*, modified volumetric modulated
arc therapy.
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underline the best technique that would preserve the AISB and
reduce the risk of radiation-induced diseases.12 The most used
constraint was V45 < 195 cc according to Quantitative Analyses
of Normal Tissue Effects in the Clinic (QUANTEC) for SB,13
and this was also studied during the plan comparison. Treat-
ments were not given at the same regimen of doses; therefore,
we calculated the equivalent V45 on each composite dosimetry
in two different ways: if the whole treatment was given in frac-
tions of 3Gy or 4Gy.
RESULTS
Delivered treatment
A total dose of 20Gy in five fractions of 4Gy was delivered to
the PTV in 1 week without any acute gastrointestinal toxicity.
The results are presented in Table 1 a.
Plan comparison
The RT plans are presented in Figure 1. We compared the con-
formity index14 of the PTV for each technique. We compared
the dose received by the SB and the AISB with each technique.
The results are presented in Table 1 a.
Composite dosimetry comparison
V45 was converted to EQD2, with an a/b ratio of 2Gy for the
SB. In 3Gy fractions, V45 corresponded to V36EQD2, and in
4Gy fractions, it corresponded to V30EQD2. The Dmax of AISB
and V45 of SB were compared for each technique and the results
are presented in Table 1 b.
DISCUSSION
Oncology now deals with cancer patients with prolonged survival
and radiologists are increasingly being solicited to perform re-
irradiation. The use of re-irradiation is limited by the risks of
complications and there is a need for dose/volume optimization,
especially with high doses in curative treatments. DIR is a very
interesting technology for multimodality image fusion, dose
accumulation or anatomic image segmentation.15 Dose warping
using DIR is useful in evaluating the dose accumulation between
previous and current RT plans for re-irradiated patients. With
IMRT, the concept of inverse planning allows us to spare virtual
structures as OAR. Our methodology using deformable registra-
tion by creating virtual constraint volumes represents an interest-
ing alternative to the usual techniques to secure re-irradiation.
It must be pointed out that, in this study, we used dose deforma-
tion to create new constraint structures. However, in this case, the
DIR software also allows to proceed to cumulative dosimetry16 in
order to better appreciate the re-irradiation parameters. For that
reason, during cumulative dosimetry, some uncertainties have to
be taken into account. In fact, rigid deformation is more accurate
than deformable registration17–19 and several anatomic changes
can disturb the accuracy of the registration. Nonetheless, the pel-
vis is probably the best area to proceed with deformable registra-
tion, as the sacroiliac bones help in controlling the accuracy of the
registration. Deformable registration is not recommended in case
of major anatomic changes to avoid errors.
In the case described previously, we showed the efficiency of our
technique. The major interest of this technique is in securing
Table 1. Dosimetric results of the second treatment with different techniques and the second treatment and composite values
VMAT* VMAT 3D RT
(a) Second treatment only
PTV
D95 (Gy) 18.6 18.9 15
SB
Dmax(Gy) 21 20.7 21.5
AISB
Dmax(Gy) 18.6 20 14.9
Conformity index
(TV/PTV)
0.89 0.88 0.35
(b) Composite dosimetry
SB
V30EQD2 (cc) 312.3 312.7 97.5
V36EQD2 (cc) 4.3 50 1.6
AISB
Dmax(Gy) 39.5 47.9 43.1
Dmax EQD2 (Gy) 46.8 60 52
3D RT, three-dimensional conformal radiotherapy; AISB, already irradiated small bowel; Dmax, maximum dose; EQD2, dose
equivalent in 2 Gy per fraction; PTV, planning treatment volume; SB, small bowel; TV, treated volume; VMAT, volumetric modulated
arc therapy; VMAT*, modified volumetric modulated arc therapy.
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re-irradiation and increasing its clinical efficacy. With the use of
this technique, the TPS can be forced to avoid a high-risk zone
with controlled dose degradation to the PTV. In addition, modi-
fied VMAT was the only technique that did not exceed 50Gy as
Dmax and was the best technique for most dosimetric parame-
ters. At final verification, the physician should consider three RT
plans: the first treatment, the new treatment plan and the com-
posite dosimetry. Each element gives information, and, there-
fore, cumulative dosimetry should not be the only element of
decision-making because of the risk of errors related to
deformable registration.
A limitation of this study was the impossibility to use the
composite dose–volume histogram value to determine the
Dmax because of the use of different fractionation regimens.
For the same reason, the exact V45 value could not be deter-
mined. A case without fractionation modification would be
more convenient to appreciate these parameters. In the most
pessimistic scenario, V30EQD2 was superior to 195 cc but it is
overestimated. In fact, most of the treatment was given in
fractions of 3Gy. Then, the most realistic value of V45 was
closer to V36EQD2 than V30EQD2, which was acceptable with
all techniques. Finally, it could be of interest to evaluate the
duration of this procedure to show that it does not extend
the planning process.
CONCLUSION
In conclusion, we presented a methodology for re-irradiation
that takes the previous irradiation into account and optimizes
the dose delivered to the patient. There is no practical difficulty
for the medical teams who are familiar with IMRT techniques
and have access to DIR software to use this technique. Thanks to
DIR, we can perhaps offer re-irradiation more often and deliver
safer treatment to patients.
CONSENT
Informed consent was obtained and held on medical records.
Patient data has been anonymized.
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